Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1996 Nov;49(11):903–908. doi: 10.1136/jcp.49.11.903

Evidence based practice: clinicians' use and attitudes to near patient testing in hospitals.

T A Gray 1, D B Freedman 1, D Burnett 1, A Szczepura 1, C P Price 1
PMCID: PMC500829  PMID: 8944609

Abstract

AIM: To survey the use made of laboratory services for urgent tests and clinicians' attitudes to near patient testing. METHODS: A questionnaire was sent to clinicians working in acute hospitals within Trent and North West Thames Regions. RESULTS: 197 replies were received. Most demand came from intensive care units. Overall, clinicians requested a median of six urgent tests a day. Blood glucose and dip stick urine testing were the most commonly performed bedside tests, but 41% of clinicians did not use ward testing. The most frequently cited indication for bedside testing was the need for speed. 85% of clinicians trusted results obtained in their central hospital laboratory, but there was an almost equal division between those who did (34%) and those who did not (38%) trust the results from near patient testing. A slightly larger proportion indicated they would accept responsibility (44%) for results obtained on the ward than would not (35%). Most staff indicated that better transport to the laboratory would remove the need for near patient testing. CONCLUSIONS: Clinicians have demonstrated an apparent need for rapid response testing but there is a strong preference for rapid transport systems and central laboratory analysis rather than bedside testing as a solution to this problem. There is a need to investigate the clinical and cost-effectiveness of near patient testing as a solution to rapid response testing.

Full text

PDF
903

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burnett D., Freedman D. Near-patient testing: the management issues. Health Serv Manage. 1994 Mar;90(3):10-1, 13. [PubMed] [Google Scholar]
  2. Burrin J. M., Fyffe J. A. Diagnostic equipment outside the laboratory. J Clin Pathol. 1988 Sep;41(9):925–928. doi: 10.1136/jcp.41.9.925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Greendyke R. M. Cost analysis. Bedside blood glucose testing. Am J Clin Pathol. 1992 Jan;97(1):106–107. doi: 10.1093/ajcp/97.1.106. [DOI] [PubMed] [Google Scholar]
  4. Lathrop J. P. The patient-focused hospital. Healthc Forum J. 1991 Jul-Aug;34(4):16-9, 21. [PubMed] [Google Scholar]
  5. Lee-Lewandrowski E., Laposata M., Eschenbach K., Camooso C., Nathan D. M., Godine J. E., Hurxthal K., Goff J., Lewandrowski K. Utilization and cost analysis of bedside capillary glucose testing in a large teaching hospital: implications for managing point of care testing. Am J Med. 1994 Sep;97(3):222–230. doi: 10.1016/0002-9343(94)90004-3. [DOI] [PubMed] [Google Scholar]
  6. Marks V. Clinical biochemistry nearer the patient. Br Med J (Clin Res Ed) 1983 Apr 9;286(6372):1166–1167. doi: 10.1136/bmj.286.6372.1166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Mennemeyer S. T., Winkelman J. W. Searching for inaccuracy in clinical laboratory testing using Medicare data. Evidence for prothrombin time. JAMA. 1993 Feb 24;269(8):1030–1033. [PubMed] [Google Scholar]
  8. Parvin C. A., Lo S. F., Deuser S. M., Weaver L. G., Lewis L. M., Scott M. G. Impact of point-of-care testing on patients' length of stay in a large emergency department. Clin Chem. 1996 May;42(5):711–717. [PubMed] [Google Scholar]
  9. Price C. P., Burrin J. M., Nattrass M. Extra-laboratory blood glucose measurement: a policy statement. Diabet Med. 1988 Oct;5(7):705–709. doi: 10.1111/j.1464-5491.1988.tb01091.x. [DOI] [PubMed] [Google Scholar]
  10. Rink E., Hilton S., Szczepura A., Fletcher J., Sibbald B., Davies C., Freeling P., Stilwell J. Impact of introducing near patient testing for standard investigations in general practice. BMJ. 1993 Sep 25;307(6907):775–778. doi: 10.1136/bmj.307.6907.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Winkelman J. W., Wybenga D. R., Tanasijevic M. J. The fiscal consequences of central vs distributed testing of glucose. Clin Chem. 1994 Aug;40(8):1628–1630. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES